2024-516291-16-00招募中1 期
Study to Evaluate the PK and Safety of Oral Decitabine and Cedazuridine in Cancer Patients with Renal Impairment
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 46
- 试验地点
- 10
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
Aram Oganesian
Scientific
Taiho Oncology Inc.
研究点 (10)
Loading locations...
相似试验
招募中
1 期
Study to Evaluate the PK and Safety of Oral Decitabine and Cedazuridine in Cancer Patients with Hepatic Impairment2024-516292-33-00Taiho Oncology Inc.50
已完成
4 期
The evaluation of the efficacy and safety of oral fingolimod in relapsing remitting multiple sclerosismultiple sclerosis.Disseminated Multiple SclerosisIRCT201406018323N10Vice-chancellor for research, Kermanshah University of Medical Sciences60
进行中（未招募）
不适用
Eficacia y seguridad de una administración oral diaria de S06911 (combinación fija de ranelato de estroncio 2g / vitamina D3 1000UI) en la deficiencia de vitamina D para el tratamiento de la osteoporosis en mujeres postmenopáusicas y hombres Estudio internacional, de fase III, prospectivo, de 12 meses de duración en abierto con un grupo de tratamiento. The efficacy and safety of a daily oral administration of S06911 (strontium ranelate 2g/vitamin D3 1000 IU fixed combination) on vitamin D deficiency in the treatment of osteoporotic postmenopausal women and men. A 12 month, prospective, open labelled, one treatment group international phase III study.Osteoporosis en hombres y mujeres postmenopáusicasMedDRA version: 9Level: LLTClassification code 10031283Term: Osteoporosis fractureMedDRA version: 9Level: LLTClassification code 10031285Term: Osteoporosis postmenopausalEUCTR2009-014270-18-ESaboratorios Servier S.L.60
已完成
3 期
Efficacy and safety of pentoxifylline in treatment and recovery of patients with COVID-19IRCT20170809035597N2Iran University of Medical Sciences150
已完成
不适用
The clinical study of the safety and efficacy of docetaxel combined with ribavirin in docetaxel resistant castration resistant prostate cancerProstate cancerJPRN-UMIN000015130Keio University School of Medicine, Department of Urology20